-

Owens & Minor Receives Prestigious Supplier Awards in Recognition of Pandemic Response

Presented by Premier, Inc., awards distinguish Owens & Minor’s contributions to help healthcare providers access critical supplies during COVID-19

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE-OMI) has been honored for its exemplary efforts supporting continuity of essential healthcare supplies during the pandemic with the receipt of two awards: the 2021 Supplier Legacy Award and the COVID-19 Award for Most Supportive Supplier.

Presented by Premier Inc., a leading healthcare improvement and technology company, the awards recognize Owens & Minor’s innovation, industry fellowship, and leadership during the global crisis.

“Owens & Minor has been an incredible partner to Premier and our members, collaborating to source hard-to-procure materials throughout the pandemic,” said David A. Hargraves, Senior Vice President of Supply Chain at Premier. “Their proactive nature and responsiveness to member requests were both notable and deeply valued, and we remain grateful for their team’s ongoing collaboration.”

Owens & Minor took swift action during the earliest days of the pandemic, implementing robust safety protocols and ramping up Americas-based manufacturing to help maintain supply resiliency in the midst of extraordinary circumstances. As the needs of healthcare providers continue to evolve, Owens & Minor remains focused on supply resilience and driving ongoing efficiency for its healthcare customers.

“Throughout each phase of the industry’s collective COVID-19 response, Owens & Minor’s top priority was serving our Mission of Empowering Our Customers to Advance Healthcare,” said Edward A. Pesicka, President and CEO of Owens & Minor. “We’re extremely honored to be recognized by a trusted partner like Premier for our contributions and look forward to continuing to serve the healthcare community with outstanding service and innovative solutions for an ever-changing industry landscape.”

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services to deliver significant and sustained value across the breadth of the industry – from acute care to patients in their home. Aligned to its Mission of Empowering Our Customers to Advance HealthcareTM, more than 15,000 global teammates serve over 4,000 healthcare industry customers. A vertically-integrated, predominantly Americas-based footprint enables Owens & Minor to reliably supply its self-manufactured surgical and PPE products. This seamless value chain integrates with a portfolio of products representing 1,200 branded suppliers. Operating continuously since 1882 from its headquarters in Richmond, Virginia, Owens & Minor has grown into a FORTUNE 500 company with operations located across North America, Asia, Europe and Latin America. For more information about Owens & Minor, visit owens-minor.com, follow @Owens_Minor on Twitter and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

Contacts

Media: Heather Sabharwal, Sr. Manager, Media Relations, media@owens-minor.com

Investors: Chandrika Nigam, Director, Investor Relations, investor.relations@owens-minor.com

Owens & Minor, Inc. LogoOwens & Minor, Inc. Logo

Owens & Minor, Inc.

NYSE:ACH
Details
Headquarters: Richmond, VA
CEO: Edward Pesicka
Employees: 6000
Organization: PUB

Release Summary
Awarded by Premier Inc
Release Versions

Contacts

Media: Heather Sabharwal, Sr. Manager, Media Relations, media@owens-minor.com

Investors: Chandrika Nigam, Director, Investor Relations, investor.relations@owens-minor.com

More News From Owens & Minor, Inc.

Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with the NYSE’s continued listing standards because the average closing price of the Company’s Class A Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period. The Notice does not result in the im...

Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer. Gardner-Smith, who has served on the Company’s Board of Directors since March 2022, is expected to assume the role early in the fourth quarter 2026. He will succeed Edward A. Pesicka, who announced his intent to retire in August. Gardner-Smith brings deep experience running large-scale patient care operations and guiding...

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health (the “Company”) is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer. Given recent market conditions, the Company has determined that it is in the best interest of stakeholders not to put in place an at-the-market issuance program. The program was intended to allow the Company to opportunistically issue modest amounts of equity over time, with the proceeds to be used to reduce o...
Back to Newsroom